Literature DB >> 9398910

Susceptibility of Helicobacter pylori to the bactericidal activity of human serum.

G Gonzalez-Valencia1, G I Perez-Perez, R G Washburn, M J Blaser.   

Abstract

BACKGROUND: Human serum represents an important barrier to the entry of most mucosal organisms into tissues and to the systemic circulation. If at all present, Helicobacter pylori within gastric tissue is rare, and bacteremia for this organism has been described only once.
METHODS: To assess the susceptibility of H. pylori to the bactericidal activity present in normal human serum (NHS), we examined 13 H. pylori isolates. To assess the contributions of the classical and alternative complement pathways to killing, we added either C2-deficient or factor B-deficient serum, respectively, to heat-inactivated NHS. Also we assessed the ability of the strains to bind 125I-C3.
RESULTS: After incubation for 60 minutes at 37 degrees C, all 13 H. pylori strains were killed by NHS; heating to 56 degrees C for 30 minutes ablated killing, indicating complement dependence for this phenomenon. In the absence of an antibody source, there was no killing when either an alternative or classical complement pathway source was used. Adding B-deficient serum to heat-inactivated normal human serum did not restore killing, but adding C2-deficient serum permitted partial killing. All of the 13 strains bound 125I-C3. Although the kinetics varied from strain to strain, C3 bound was significantly correlated (r = 0.61, p = 0.03) with serum susceptibility.
CONCLUSIONS: H. pylori are susceptible to complement, alternative pathway activation appears critical, and C3 binding is a major locus of variability.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9398910     DOI: 10.1111/j.1523-5378.1996.tb00005.x

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  9 in total

1.  Is Helicobacter pylori a factor in coronary atherosclerosis?

Authors:  J Danesh; J Koreth; L Youngman; R Collins; J R Arnold; Y Balarajan; J McGee; D Roskell
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

2.  Relation of Helicobacter pylori infection and angiographically demonstrated coronary artery disease.

Authors:  C J Tsai; T Y Huang
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

3.  Usefulness of adult bovine serum for Helicobacter pylori culture media.

Authors:  Keigo Shibayama; Mitsuaki Nagasawa; Takafumi Ando; Masaaki Minami; Jun-ichi Wachino; Satowa Suzuki; Yoshichika Arakawa
Journal:  J Clin Microbiol       Date:  2006-09-06       Impact factor: 5.948

Review 4.  Helicobacter pylori interactions with host serum and extracellular matrix proteins: potential role in the infectious process.

Authors:  J Daniel Dubreuil; Giuseppe Del Giudice; Rino Rappuoli
Journal:  Microbiol Mol Biol Rev       Date:  2002-12       Impact factor: 11.056

5.  Serum bactericidal activity against Helicobacter pylori in patients with hypogammaglobulinaemia.

Authors:  I M E Desar; M van Deuren; T Sprong; J B M J Jansen; F Namavar; C M Vandenbroucke-Grauls; J W M van der Meer
Journal:  Clin Exp Immunol       Date:  2009-06       Impact factor: 4.330

6.  Alzheimer's Disease: APP, Gamma Secretase, APOE, CLU, CR1, PICALM, ABCA7, BIN1, CD2AP, CD33, EPHA1, and MS4A2, and Their Relationships with Herpes Simplex, C. Pneumoniae, Other Suspect Pathogens, and the Immune System.

Authors:  Chris Carter
Journal:  Int J Alzheimers Dis       Date:  2011-12-29

7.  Campylobacter jejuni strains from patients with Guillain-Barré syndrome.

Authors:  B M Allos; F T Lippy; A Carlsen; R G Washburn; M J Blaser
Journal:  Emerg Infect Dis       Date:  1998 Apr-Jun       Impact factor: 6.883

8.  Geranylgeranylacetone selectively binds to the HSP70 of Helicobacter pylori and alters its coccoid morphology.

Authors:  Ewa Grave; Shin-ichi Yokota; Soh Yamamoto; Arisa Tamura; Takako Ohtaki-Mizoguchi; Kenji Yokota; Keiji Oguma; Kazuhiko Fujiwara; Nobuaki Ogawa; Tomoya Okamoto; Michiro Otaka; Hideaki Itoh
Journal:  Sci Rep       Date:  2015-09-08       Impact factor: 4.379

Review 9.  Diagnosis, treatment, and outcome in patients with bleeding peptic ulcers and Helicobacter pylori infections.

Authors:  Ting-Chun Huang; Chia-Long Lee
Journal:  Biomed Res Int       Date:  2014-06-30       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.